%0 Journal Article %1 Gervas2002 %A Gérvas, Juan %A Fernández, Mercedes Pérez %D 2002 %J Medicina clínica %K BiologicalMarkers ClinicalTrialsasTopic Humans Hydroxymethylglutaryl-CoAReductaseInhibitors Hydroxymethylglutaryl-CoAReductaseInhibitors:ad Hydroxymethylglutaryl-CoAReductaseInhibitors:th Pyridines Pyridines:adverseeffects Pyridines:therapeuticuse Risk TreatmentOutcome %N 7 %P 254-9 %T Surrogate end points as a clinical and public health problem. The cerivastatin case. %U http://www.ncbi.nlm.nih.gov/pubmed/12236985 %V 119 %@ 0025-7753

@article{Gervas2002, added-at = {2023-02-03T11:44:35.000+0100}, author = {Gérvas, Juan and Fernández, Mercedes Pérez}, biburl = {https://www.bibsonomy.org/bibtex/2c9effe9572c346a6e5291d7408683237/jepcastel}, city = {Medico general, Canencia de la Sierra, Madrid, Spain. jgervasc@meditex.es}, interhash = {4bc073a1f6fd055e816e905a621b7281}, intrahash = {c9effe9572c346a6e5291d7408683237}, isbn = {0025-7753}, issn = {0025-7753}, journal = {Medicina clínica}, keywords = {BiologicalMarkers ClinicalTrialsasTopic Humans Hydroxymethylglutaryl-CoAReductaseInhibitors Hydroxymethylglutaryl-CoAReductaseInhibitors:ad Hydroxymethylglutaryl-CoAReductaseInhibitors:th Pyridines Pyridines:adverseeffects Pyridines:therapeuticuse Risk TreatmentOutcome}, month = {9}, note = {4311<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 0376377; 0 (Biological Markers); 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); 0 (Pyridines); 0 (cerivastatin); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades}, number = 7, pages = {254-9}, pmid = {12236985}, timestamp = {2023-02-03T11:44:35.000+0100}, title = {[Surrogate end points as a clinical and public health problem. The cerivastatin case].}, url = {http://www.ncbi.nlm.nih.gov/pubmed/12236985}, volume = 119, year = 2002 }